The Calcium-Sensing Receptor Increases Activity of the Renal NCC through the WNK4-SPAK Pathway.
暂无分享,去创建一个
D. Ellison | R. Bautista | N. Vázquez | María Castañeda-Bueno | G. Gamba | D. Riccardi | N. Bobadilla | L. G. Cervantes-Pérez | Lorena Rojas-Vega | C. Plata | J. Barrera-Chimal | L. González-Mariscal | A. Murillo-de-Ozores | Silvana Bazúa-Valenti | Lorena Rojas‐vega | L. Cervantes-Perez | Luz G Cervantes-Perez
[1] S. Minisola,et al. Cardiovascular manifestations of primary hyperparathyroidism: a narrative review. , 2017, European journal of endocrinology.
[2] R. Lifton,et al. Phosphorylation by PKC and PKA regulate the kinase activity and downstream signaling of WNK4 , 2017, Proceedings of the National Academy of Sciences.
[3] Y. Yagi,et al. Small-molecule WNK inhibition regulates cardiovascular and renal function. , 2016, Nature chemical biology.
[4] Jenny J. Yang,et al. Molecular Basis of the Extracellular Ligands Mediated Signaling by the Calcium Sensing Receptor , 2016, Front. Physiol..
[5] K. Sakaguchi,et al. Positive Allosteric Modulation of the Calcium-sensing Receptor by Physiological Concentrations of Glucose* , 2016, The Journal of Biological Chemistry.
[6] C. Schöfl,et al. Activating Calcium-Sensing Receptor Mutations: Prospects for Future Treatment with Calcilytics , 2016, Trends in Endocrinology & Metabolism.
[7] G. Valenti,et al. Localization and function of the renal calcium-sensing receptor , 2016, Nature Reviews Nephrology.
[8] H. Dörr,et al. GENETICS IN ENDOCRINOLOGY: Gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts. , 2016, European journal of endocrinology.
[9] D. Riccardi,et al. Comparative expression of the extracellular calcium-sensing receptor in the mouse, rat, and human kidney. , 2016, American journal of physiology. Renal physiology.
[10] D. Ellison,et al. Regulation of Renal Electrolyte Transport by WNK and SPAK-OSR1 Kinases. , 2016, Annual review of physiology.
[11] G. Gamba,et al. Mini-review: regulation of the renal NaCl cotransporter by hormones. , 2016, American journal of physiology. Renal physiology.
[12] M. Chonchol,et al. Renal control of calcium, phosphate, and magnesium homeostasis. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[13] P. Houillier,et al. Calcium Sensing in the Renal Tubule. , 2015, Physiology.
[14] María Castañeda-Bueno,et al. Ovarian hormones and prolactin increase renal NaCl cotransporter phosphorylation. , 2015, American journal of physiology. Renal physiology.
[15] J. Schnermann,et al. Integrated control of Na transport along the nephron. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[16] D. Ellison,et al. The Effect of WNK4 on the Na+:Cl‐ Cotransporter is modulated by Intracellular Chloride , 2015, Journal of the American Society of Nephrology : JASN.
[17] H. Cheong,et al. Autosomal dominant hypocalcemia with Bartter syndrome due to a novel activating mutation of calcium sensing receptor, Y829C , 2015, Korean journal of pediatrics.
[18] A. Subramanya,et al. Distal convoluted tubule. , 2014, Clinical journal of the American Society of Nephrology : CJASN.
[19] X. Jeunemaître,et al. WNK-SPAK-NCC Cascade Revisited: WNK1 Stimulates the Activity of the Na-Cl Cotransporter via SPAK, an Effect Antagonized by WNK4 , 2014, Hypertension.
[20] R. Lifton,et al. Angiotensin II signaling via protein kinase C phosphorylates Kelch-like 3, preventing WNK4 degradation , 2014, Proceedings of the National Academy of Sciences.
[21] H. Toka,et al. The role of the calcium-sensing receptor in disorders of abnormal calcium handling and cardiovascular disease , 2014, Current opinion in nephrology and hypertension.
[22] R. Fenton,et al. Renal phosphate wasting in the absence of adenylyl cyclase 6. , 2014, Journal of the American Society of Nephrology : JASN.
[23] Ann D Colosia,et al. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review , 2013, Diabetes, metabolic syndrome and obesity : targets and therapy.
[24] R. Lifton,et al. Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4 , 2013, Proceedings of the National Academy of Sciences.
[25] R. Bautista,et al. Insulin increases the functional activity of the renal NaCl cotransporter , 2013, Journal of hypertension.
[26] L. Schild,et al. Sodium Chloride Transport in the Loop of Henle, Distal Convoluted Tubule, and Collecting Duct , 2013 .
[27] G. Gamba. Regulation of the renal Na+-Cl- cotransporter by phosphorylation and ubiquitylation. , 2012, American journal of physiology. Renal physiology.
[28] E. Brown,et al. Deficiency of the calcium-sensing receptor in the kidney causes parathyroid hormone-independent hypocalciuria. , 2012, Journal of the American Society of Nephrology : JASN.
[29] P. Houillier,et al. PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor. , 2012, The Journal of clinical investigation.
[30] D. Alessi,et al. Activation of the renal Na+:Cl− cotransporter by angiotensin II is a WNK4-dependent process , 2012, Proceedings of the National Academy of Sciences.
[31] Jai Radhakrishnan,et al. Mutations in Kelch-like 3 and Cullin 3 cause hypertension and electrolyte abnormalities , 2012, Nature.
[32] D. Ward,et al. New concepts in calcium‐sensing receptor pharmacology and signalling , 2012, British journal of pharmacology.
[33] The influence of extracellular and intracellular calcium on the secretion of renin , 2012, Pflügers Archiv - European Journal of Physiology.
[34] G. Desir,et al. The evidence-based use of thiazide diuretics in hypertension and nephrolithiasis. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[35] Douglas K. Atchison,et al. Acute activation of the calcium-sensing receptor inhibits plasma renin activity in vivo. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.
[36] D. Alessi,et al. Role of the WNK-activated SPAK kinase in regulating blood pressure , 2010, EMBO molecular medicine.
[37] S. Sasaki,et al. Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion and lowers blood pressure. , 2009, Human molecular genetics.
[38] C. Wagner,et al. The calcium-sensing receptor promotes urinary acidification to prevent nephrolithiasis. , 2009, Journal of the American Society of Nephrology : JASN.
[39] D. Riccardi,et al. Activation of the Ca2+-sensing receptor stimulates the activity of the epithelial Ca2+ channel TRPV5. , 2009, Cell calcium.
[40] R. Lifton,et al. Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway , 2009, Proceedings of the National Academy of Sciences.
[41] P. A. Friedman,et al. Thick ascending limb: the Na+:K+:2Cl− co-transporter, NKCC2, and the calcium-sensing receptor, CaSR , 2009, Pflügers Archiv - European Journal of Physiology.
[42] D. Alessi,et al. Activation of the thiazide-sensitive Na+-Cl– cotransporter by the WNK-regulated kinases SPAK and OSR1 , 2008, Journal of Cell Science.
[43] S. de Seigneux,et al. Calcium-sensing receptor attenuates AVP-induced aquaporin-2 expression via a calmodulin-dependent mechanism. , 2008, Journal of the American Society of Nephrology : JASN.
[44] H. Chen,et al. Effects of furosemide on renal calcium handling. , 2007, American journal of physiology. Renal physiology.
[45] N. Vázquez,et al. The Na+:Cl– Cotransporter Is Activated and Phosphorylated at the Amino-terminal Domain upon Intracellular Chloride Depletion* , 2006, Journal of Biological Chemistry.
[46] D. Ellison,et al. Pathophysiology of functional mutations of the thiazide-sensitive Na-Cl cotransporter in Gitelman disease. , 2004, American journal of physiology. Renal physiology.
[47] C. Saunders,et al. Calcium-sensing Receptor-mediated ERK1/2 Activation Requires Gαi2 Coupling and Dynamin-independent Receptor Internalization* , 2004, Journal of Biological Chemistry.
[48] D. Ward. Calcium receptor-mediated intracellular signalling. , 2004, Cell calcium.
[49] D. Lacey,et al. Pharmacodynamics of the Type II Calcimimetic Compound Cinacalcet HCl , 2004, Journal of Pharmacology and Experimental Therapeutics.
[50] N. Roinel,et al. Ca2+, Mg2+ and K+ transport in the cortical and medullary thick ascending limb of the rat nephron: influence of transepithelial voltage , 1993, Pflügers Archiv.
[51] P. Houillier,et al. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. , 2002, Journal of the American Society of Nephrology : JASN.
[52] Y. Takeuchi,et al. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome , 2002, The Lancet.
[53] Robert J. Unwin,et al. Human Hypertension Caused by Mutations in WNK Kinases , 2001, Science.
[54] H. Lother,et al. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration , 2000, Nature.
[55] G. Gamba,et al. Characterization of the thiazide-sensitive Na(+)-Cl(-) cotransporter: a new model for ions and diuretics interaction. , 2000, American journal of physiology. Renal physiology.
[56] P. Cohen,et al. Specificity and mechanism of action of some commonly used protein kinase inhibitors. , 2000, The Biochemical journal.
[57] E. Nemeth,et al. NPS R-568: a type II calcimimetic compound that acts on parathyroid cell calcium receptor of rats to reduce plasma levels of parathyroid hormone and calcium. , 1999, The Journal of pharmacology and experimental therapeutics.
[58] J. Han,et al. Decreased aquaporin-2 expression and apical plasma membrane delivery in kidney collecting ducts of polyuric hypercalcemic rats. , 1998, Journal of the American Society of Nephrology : JASN.
[59] M F Balandrin,et al. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[60] E. Brown,et al. Localization of the extracellular Ca2+/polyvalent cation-sensing protein in rat kidney. , 1998, American journal of physiology. Renal physiology.
[61] E. Brown,et al. The extracellular calcium-sensing receptor: its role in health and disease. , 1998, Annual review of medicine.
[62] P. A. Friedman,et al. Codependence of renal calcium and sodium transport. , 1998, Annual review of physiology.
[63] H. W. Harris,et al. Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. , 1997, The Journal of clinical investigation.
[64] E. Brown,et al. Localization of the extracellular Ca(2+)-sensing receptor and PTH/PTHrP receptor in rat kidney. , 1996, The American journal of physiology.
[65] E. Brown,et al. Expression and Characterization of Inactivating and Activating Mutations in the Human Ca2+o-sensing Receptor* , 1996, The Journal of Biological Chemistry.
[66] R. Lifton,et al. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na–K–2CI cotransporter NKCC2 , 1996, Nature Genetics.
[67] M. Hediger,et al. Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid , 1993, Nature.
[68] P. A. Friedman,et al. Mechanism of calcium transport stimulated by chlorothiazide in mouse distal convoluted tubule cells. , 1992, The Journal of clinical investigation.
[69] R. Pearson,et al. Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. , 1991, Methods in enzymology.
[70] T. Berl,et al. Mechanism of concentrating defect in hypercalcemia. Role of polydipsia and prostaglandins. , 1983, Kidney international.
[71] G. Eknoyan,et al. Acute treatment of hypercalcemia with furosemide. , 1970, The New England journal of medicine.
[72] J. Gill,et al. On the impairment of renal concentrating ability in prolonged hypercalcemia and hypercalciuria in man. , 1961, The Journal of clinical investigation.